Member Log-in

I forgot my password

Not a Member? Register

Current Vaccine Pricing for GAVI Transitioning Countries

The World Health Organization has presented a useful fact sheet summarizing information on prices for pentavalent, PCV, Rota, and HPV vaccines in Gavi transitioning countries who procure through UN agencies.

This document has been prepared by the Expanded Programme on Immunization (EPI) of the Department of Immunization, Vaccines and Biologicals. It is a working document. This version of the fact sheet is up to date as of November 2017, and may not reflect the most up-to-date and accurate pricing information. For more information on this document or on vaccine price and procurement, please email V3P-project@who.int.

Click here for the document.

You May Also Like

Vaccine Procurement in the Middle East and North Africa Region: Challenges and Ways of Improving Program Efficiency and Fiscal Space

Abstract Improving vaccine procurement performance has been a priority concern of national health authorities in the Middle East and North Africa (MENA) region for years particularly in terms of its role in accessing new vaccines and assuring a steady supply of quality vaccines at affordable prices. This article reviews the vaccine procurement mechanisms in the … Continued

Aggregating Demand for Pharmaceuticals is Appealing, but Pooling Is Not a Panacea

As low- and middle-income countries reduce their reliance on donor aid, they are increasingly obliged to assume some degree of financial responsibility for donor projects. This challenge will be particularly complex in the procurement of health commodities. In recent decades, recipient countries have benefited from donor-aggregated demand and pooling mechanisms, negotiated prices, purchasing, and delivery … Continued

Sustaining Pneumococcal Vaccination After Transitioning from Gavi Support: A Modelling and Cost-effectiveness Study in Kenya

Background In 2009, Gavi, the World Bank, and donors launched the pneumococcal Advance Market Commitment, which helped countries access more affordable pneumococcal vaccines. As many low-income countries begin to reach the threshold at which countries transition from Gavi support to self-financing (3-year average gross national income per capita of US$1580), they will need to consider … Continued

Choose a Language